These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 22986539)
1. Microbial transformation of 20(S)-protopanaxatriol by Absidia corymbifera and their cytotoxic activities against two human prostate cancer cell lines. Chen G; Yang X; Zhai X; Yang M Biotechnol Lett; 2013 Jan; 35(1):91-5. PubMed ID: 22986539 [TBL] [Abstract][Full Text] [Related]
2. Microbial transformation of 20(S)-protopanaxadiol by Absidia corymbifera. Cytotoxic activity of the metabolites against human prostate cancer cells. Chen G; Yang M; Nong S; Yang X; Ling Y; Wang D; Wang X; Zhang W Fitoterapia; 2013 Jan; 84():6-10. PubMed ID: 23022533 [TBL] [Abstract][Full Text] [Related]
3. Two novel hydroperoxylated products of 20(S)-protopanaxadiol produced by Mucor racemosus and their cytotoxic activities against human prostate cancer cells. Chen G; Yang X; Nong S; Yang M; Xu B; Zhang W Biotechnol Lett; 2013 Mar; 35(3):439-43. PubMed ID: 23183919 [TBL] [Abstract][Full Text] [Related]
4. Biotransformation of 20(S)-protopanaxatriol by Mucor spinosus and the cytotoxic structure activity relationships of the transformed products. Zhang J; Guo H; Tian Y; Liu P; Li N; Zhou J; Guo D Phytochemistry; 2007 Oct; 68(20):2523-30. PubMed ID: 17624380 [TBL] [Abstract][Full Text] [Related]
5. Microbial transformation of 20(S)-protopanaxatriol by Mucor spinosus. Yang X; Ge H; Song Y; Li J; Chen G Biotechnol Lett; 2015 Feb; 37(2):397-402. PubMed ID: 25257595 [TBL] [Abstract][Full Text] [Related]
6. Microbial transformation of 20(S)-protopanaxatriol by Mucor spinosus. Tian Y; Guo H; Han J; Guo D J Nat Prod; 2005 May; 68(5):678-80. PubMed ID: 15921408 [TBL] [Abstract][Full Text] [Related]
7. Microbial transformation of ginsenoside-Rg₁ by Absidia coerulea and the reversal activity of the metabolites towards multi-drug resistant tumor cells. Liu X; Qiao L; Xie D; Zhang Y; Zou J; Chen X; Dai J Fitoterapia; 2011 Dec; 82(8):1313-7. PubMed ID: 21946057 [TBL] [Abstract][Full Text] [Related]
8. Biotransformation of 20(S)-protopanaxatriol by Mucor racemosus and the anti-cancer activities of some products. Chen G; Ge H; Song Y; Li J; Zhai X; Wu J; Ling X Biotechnol Lett; 2015 Oct; 37(10):2005-9. PubMed ID: 26054722 [TBL] [Abstract][Full Text] [Related]
9. Biotransformation of 20(S)-protopanaxadiol by Mucor spinosus. Li H; Ye M; Guo H; Tian Y; Zhang J; Zhou J; Hu Y; Guo D Phytochemistry; 2009; 70(11-12):1416-20. PubMed ID: 19732918 [TBL] [Abstract][Full Text] [Related]
10. Antitumor agents. 261. 20(S)-protopanaxadiol and 20(s)-protopanaxatriol as antiangiogenic agents and total assignment of (1)H NMR spectra. Usami Y; Liu YN; Lin AS; Shibano M; Akiyama T; Itokawa H; Morris-Natschke SL; Bastow K; Kasai R; Lee KH J Nat Prod; 2008 Mar; 71(3):478-81. PubMed ID: 18271556 [TBL] [Abstract][Full Text] [Related]
11. Novel microbial transformation of resibufogenin by Absidia coerules. Zheng J; Su DH; Zhang DS; Xin XL; Liu JY; Tian Y; Wei Q; Cui X Nat Prod Commun; 2011 Nov; 6(11):1581-4. PubMed ID: 22224264 [TBL] [Abstract][Full Text] [Related]
12. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer. Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302 [TBL] [Abstract][Full Text] [Related]
13. (R)-panaxadiol by whole cells of filamentous fungus Absidia coerulea AS 3.3382. Song Y; Yan SS; Lin HJ; Li JL; Zhai XG; Ren J; Chen GT J Asian Nat Prod Res; 2018 Aug; 20(8):719-726. PubMed ID: 28944684 [TBL] [Abstract][Full Text] [Related]
14. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer. Musende AG; Eberding A; Wood CA; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Tomlinson Guns ES Anticancer Drugs; 2012 Jun; 23(5):543-52. PubMed ID: 22481061 [TBL] [Abstract][Full Text] [Related]
15. New cytotoxic indolic metabolites from a marine Streptomyces. Sánchez López JM; Martínez Insua M; Pérez Baz J; Fernández Puentes JL; Cañedo Hernández LM J Nat Prod; 2003 Jun; 66(6):863-4. PubMed ID: 12828477 [TBL] [Abstract][Full Text] [Related]
16. Microbial transformation of cinobufagin by Syncephalastrum racemosum. Ma XC; Xin XL; Liu KX; Han J; Guo DA J Nat Prod; 2008 Jul; 71(7):1268-70. PubMed ID: 18558746 [TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
18. Microbial transformation of isosteviol and bioactivities against the glucocorticoid/androgen response elements. Chang SF; Yang LM; Lo CH; Liaw JH; Wang LH; Lin SJ J Nat Prod; 2008 Jan; 71(1):87-92. PubMed ID: 18177009 [TBL] [Abstract][Full Text] [Related]
19. Transformations of testosterone and related steroids in Absidia glauca culture. Huszcza E; Dmochowska-Gladysz J J Basic Microbiol; 2003; 43(2):113-20. PubMed ID: 12746853 [TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxic effects of imatinib in combination with anticancer drugs in human prostate cancer cell lines. Kübler HR; van Randenborgh H; Treiber U; Wutzler S; Battistel C; Lehmer A; Wagenpfeil S; Hartung R; Paul R Prostate; 2005 Jun; 63(4):385-94. PubMed ID: 15617027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]